FDA Inspection 1237963 — Tri-State Biologics Inc.
The FDA completed an inspection of Tri-State Biologics Inc. on April 29, 2024 in Secaucus, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 29, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Secaucus, NJ (United States)